Psilocybin therapy appears as effective as escitalopram, small study finds
Pharmaceutical journal/The pharmaceutical journal 2021 DOI: 10.1211/pj.2021.1.91592 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Phase II randomized controlled trial Peer reviewed |
|---|---|
| Population | Adults with depression |
| Interventions | Psilocybin therapy Escitalopram |
| Topics | Anxiety Psilocybin |
| Keywords | Escitalopram Hallucinogen Psychotherapist Antidepressant |
| Key findings | Psilocybin therapy appears to be at least as effective as escitalopram in treating depression. |
Abstract
Psilocybin therapy appears to be at least as effective as escitalopram in treating depression, findings from a small phase II study published in the New England Journal of Medicine have indicated (15 April 2021)[1]. Researchers compared two sessions of psychedelic psilocybin therapy, delivered in a specialist clinical setting, with a course of the selective serotonin […]